Related Experiment Video
Updated: Jun 24, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
E6AP promotes the degradation of the PML tumor suppressor
I Louria-Hayon1, O Alsheich-Bartok, Y Levav-Cohen
1Lautenberg Center for General and Tumour Immunology, The Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Abstract:
The promyelocytic leukemia (PML) tumor suppressor is essential for the formation of PML nuclear bodies (NBs). PML and PML-NBs have been implicated in the regulation of growth inhibition, senescence and apoptosis. PML is activated in response to stress signals and is downregulated in certain human cancers. However, the factors mediating PML stability are incompletely understood. Here we demonstrate that a catalytically active form of the mammalian E3 ligase E6AP (HPV E6-associated protein) acts to reduce the half-life of the PML protein by promoting its degradation in the proteasome. E6AP mediates the ubiquitination of PML in an in vitro ubiquitination assay. E6AP and PML interact at physiological levels and colocalize in PML-NBs. Importantly, PML protein expression is elevated in multiple organs and cell types from E6AP null mice and in lymphoid cells is associated with increased number and intensity of PML-NBs. This PML elevation is enhanced in response to DNA damage. Our results identify E6AP as an important regulator of PML and PML-NBs.
Insights
The E3 ligase E6AP targets the PML tumor suppressor for proteasomal degradation, regulating its stability and the formation of PML nuclear bodies (NBs). This discovery sheds light on PML regulation in cancer and response to DNA damage.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Regulation
Background:
- The promyelocytic leukemia (PML) tumor suppressor is crucial for PML nuclear bodies (NBs) formation.
- PML and PML-NBs are involved in regulating cell growth, senescence, and apoptosis.
- PML is activated by stress but downregulated in cancers, with factors affecting its stability being unclear.
Purpose of the Study:
- To identify factors that regulate the stability of the PML protein.
- To investigate the role of E3 ligase E6AP in PML protein degradation.
Main Methods:
- In vitro ubiquitination assays to assess E6AP's effect on PML.
- Co-immunoprecipitation to study E6AP and PML interaction.
- Analysis of PML protein expression in E6AP null mice.
Main Results:
- Catalytically active E6AP promotes PML degradation via the proteasome, reducing its half-life.
- E6AP and PML interact and colocalize within PML-NBs.
- PML protein levels and PML-NBs are elevated in E6AP null mice, particularly after DNA damage.
Conclusions:
- E6AP is identified as a key regulator of PML protein stability and PML-NB formation.
- Understanding E6AP-mediated PML regulation offers insights into cancer mechanisms and DNA damage response.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Anaphase Promoting Complex
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...